BIOMAT Database Logo BIOMAT Database Logo

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. 2008

Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Laboratory of Infectious Diseases, Third Department of Pediatrics, Aristotle University, Hippokration Hospital, 54642 Thessaloniki, Greece.

The activities of voriconazole, posaconazole, caspofungin, and anidulafungin against Candida albicans and Candida parapsilosis biofilms were evaluated. In contrast to planktonic cells, the MICs for voriconazole and posaconazole for the biofilms of the two species were high (>or=256 and >64 mg/liter, respectively) but relatively low for the echinocandins caspofungin and anidulafungin (<or=1 and <or=2 mg/liter, respectively).

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D001393 Azoles Five membered rings containing a NITROGEN atom. Azole
D054714 Echinocandins Cyclic hexapeptides of proline-ornithine-threonine-proline-threonine-serine. The cyclization with a single non-peptide bond can lead them to be incorrectly called DEPSIPEPTIDES, but the echinocandins lack ester links. Antifungal activity is via inhibition of 1,3-beta-glucan synthase production of BETA-GLUCANS. Aculeacin,Echinocandin,Pneumocandin,Aculeacins,Mulundocandins,Pneumocandins
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm

Related Publications

Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.
September 2014, Antimicrobial agents and chemotherapy,
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms.
April 2022, Antibiotics (Basel, Switzerland),
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Activities of nine antifungal agents against Candida auris biofilms.
April 2021, Mycoses,
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
September 2005, The Journal of antimicrobial chemotherapy,
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Antifungal combinations against Candida albicans biofilms in vitro.
November 2003, Antimicrobial agents and chemotherapy,
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms.
April 2011, The Journal of antimicrobial chemotherapy,
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Resistance of Candida albicans biofilms to antifungal agents in vitro.
September 1995, Antimicrobial agents and chemotherapy,
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Biofilms of Candida albicans and their associated resistance to antifungal agents.
August 2001, American clinical laboratory,
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
February 2009, Archives of oral biology,
Aspasia Katragkou, and Athanasios Chatzimoschou, and Maria Simitsopoulou, and Maria Dalakiouridou, and Eudoxia Diza-Mataftsi, and Chaido Tsantali, and Emmanuel Roilides
Antifungal activities of origanum oil against Candida albicans.
December 2001, Molecular and cellular biochemistry,
Copied contents to your clipboard!